Cotcha Yankinov
Bluelight Crew
- Joined
- Jul 21, 2015
- Messages
- 2,952
Well my two cents is (applying specifically to those who have trouble sleeping with their LTC) lowered testosterone and the symptoms of it can happen with sleep deprivation and insomnia, as well as depression. So it's possible that antipsychotics that can treat the aforementioned sleep/depression issues could restore testosterone, although lower testosterone has been seen in schizophrenics chronically treated with antipsychotics (although a lower rate of hormonal issues with Zyprexa compared to Risperidone).
But it seems to me like antipsychotics would mainly be something to try after SSRIs don't work.
What's been well studied and observed in MDD patients is higher stress hormones, which have been linked to actually causing MDD and have led the way for animal models of depression (neurogenic hypothesis of depression), and they are developing drugs to block these stress hormones (CRF antagonists). But antipsychotics do help decrease cortisol as well (https://www.ncbi.nlm.nih.gov/m/pubmed/27112637/) although they are not without their risks.
"Our findings suggest that haloperidol can directly regulate the hypothalamic-pituitary-adrenal (HPA) axis and immune system through a pharmacological action via D2 receptor antagonism. Finally, our data suggest that the increased hippocampal resting cerebral bloodflow is a manifestation of the reduction in IL-6 and cortisol which follows the administration of haloperidol."
But it seems to me like antipsychotics would mainly be something to try after SSRIs don't work.
What's been well studied and observed in MDD patients is higher stress hormones, which have been linked to actually causing MDD and have led the way for animal models of depression (neurogenic hypothesis of depression), and they are developing drugs to block these stress hormones (CRF antagonists). But antipsychotics do help decrease cortisol as well (https://www.ncbi.nlm.nih.gov/m/pubmed/27112637/) although they are not without their risks.
"Our findings suggest that haloperidol can directly regulate the hypothalamic-pituitary-adrenal (HPA) axis and immune system through a pharmacological action via D2 receptor antagonism. Finally, our data suggest that the increased hippocampal resting cerebral bloodflow is a manifestation of the reduction in IL-6 and cortisol which follows the administration of haloperidol."